What is the treatment for fifth disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Fifth Disease (Erythema Infectiosum)

Fifth disease is typically a self-limited viral illness that requires only supportive care in most cases, as there is no specific antiviral treatment available for parvovirus B19 infection. 1, 2

General Management Approach

Immunocompetent Children and Adults

  • Supportive care is the mainstay of treatment, including rest, adequate hydration, and symptomatic relief 2
  • Analgesic medications (acetaminophen or ibuprofen) can be used to manage fever, headache, and joint pain that may accompany the illness 2
  • No isolation is necessary once the characteristic rash appears, as patients are no longer contagious at this stage 1, 3
  • The prognosis is generally excellent, with complete resolution expected in immunocompetent individuals 2

Specific Clinical Scenarios Requiring Intervention

Patients with hemolytic anemia (such as sickle cell disease, hereditary spherocytosis, or thalassemia) who develop transient aplastic crisis require:

  • Red blood cell transfusions to manage severe anemia 2
  • Close monitoring of hemoglobin levels and reticulocyte counts 1

Immunocompromised patients with chronic parvovirus B19 infection and persistent anemia should receive:

  • Intravenous immunoglobulin (IVIG) as the treatment of choice 2
  • This provides passive antibodies that can clear the viral infection in patients unable to mount their own immune response 2

Pregnant Women

Pregnant women exposed to fifth disease require specific evaluation and monitoring, not treatment of the disease itself:

  • Assess maternal immune status with parvovirus B19 IgG and IgM antibodies 4
  • If IgG positive (immune), reassure the patient that risks are nil 4
  • If non-immune (IgG negative) with confirmed acute infection (IgM positive), implement serial fetal surveillance with ultrasonography every 1-2 weeks for 8-12 weeks to detect hydrops fetalis 4
  • If fetal hydrops develops, intrauterine transfusion at a tertiary care center may be lifesaving 4, 2
  • The actual risk of fetal complications is very low (less than 5% of infected pregnant women) 4

Important Clinical Caveats

  • The characteristic "slapped cheek" rash indicates the patient is past the contagious phase and viral shedding has ceased 1, 3
  • Conjunctivitis may occasionally accompany fifth disease and requires only supportive care 5
  • Adult patients more commonly develop arthropathy (joint pain and swelling) rather than the typical childhood rash, which may persist for weeks but is self-limited 1, 2
  • Diagnosis can be confirmed with serum antibody testing (IgM for acute infection, IgG for past infection or immunity) when clinical presentation is atypical 2

References

Research

Fifth (human parvovirus) and sixth (herpesvirus 6) diseases.

Current opinion in infectious diseases, 2001

Research

Erythema infectiosum and other parvovirus B19 infections.

American family physician, 1994

Research

Erythema infectiosum (Fifth disease) and pregnancy.

Canadian family physician Medecin de famille canadien, 1999

Research

Conjunctivitis associated with fifth disease in a child: a case report.

Journal of the American Optometric Association, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.